Keywords: Thrombosis, Oral anticoagulants, Market forecast, Frost & Sullivan

Urgent need for enhanced thrombosis products in Europe, says F&S

Article | 14 May 2012

The increasing incidence of thrombosis, paralleled by the maturing life cycles of existing products, are motivating the need for novel ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in